{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:05Z","timestamp":1791357485917,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.genhosppsych.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T17:33:31Z","timestamp":1613669611000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Toxicity of psychotropic drugs in patients with COVID-19: A systematic review"],"prefix":"10.1016","volume":"70","author":[{"given":"Michel","family":"Sabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Dorsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Huguelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/v12020135","article-title":"Return of the Coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0010","series-title":"Medicine","article-title":"Coronavirus ressource center","author":"JHU","year":"2020"},{"issue":"20","key":"10.1016\/j.genhosppsych.2021.02.006_bb0015","first-page":"30077","article-title":"Covid-19 treatment-induced neuropsychiatric adverse effects","volume":"S0163-8343","author":"Garc\u00eda","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-020-02882-x","article-title":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic","volume":"24","author":"Kotfis","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320942703","article-title":"Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches","volume":"10","author":"Ostuzzi","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.genhosppsych.2020.05.008","article-title":"Delirium in COVID-19: a case series and exploration of potential mechanisms for central nervous system involvement","volume":"65","author":"Beach","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: the reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0055","first-page":"1","article-title":"Clozapine treatment and risk of COVID-19 infection: retrospective cohort study","author":"Govind","year":"2020","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.genhosppsych.2020.06.013","article-title":"Physical health among people with serious mental illness in the face of COVID-19: concerns and mitigation strategies","volume":"66","author":"Melamed","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0065","first-page":"1","article-title":"Clinical characteristics of 3062 COVID-19 patients: a meta-analysis","author":"Zhu","year":"2020","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.genhosppsych.2021.02.006_bb0070","doi-asserted-by":"crossref","first-page":"2243.e1","DOI":"10.1016\/j.ajem.2020.05.042","article-title":"Neuroleptic malignant syndrome in patients with COVID-19","volume":"38","author":"Soh","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0075","doi-asserted-by":"crossref","first-page":"116944","DOI":"10.1016\/j.jns.2020.116944","article-title":"Serotonin syndrome in two COVID-19 patients treated with lopinavir\/ritonavir","volume":"415","author":"Mas Serrano","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/schbul\/sbaa070","article-title":"COVID-19 infection may cause clozapine intoxication: case report and discussion","volume":"46","author":"Cranshaw","year":"2020","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0085","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0090","first-page":"e8384","article-title":"Lithium toxicity in two coronavirus disease 2019 (COVID-19) patients","volume":"12","author":"Suwanwongse","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.genhosppsych.2021.02.006_bb0095","first-page":"20l02699","article-title":"Death from COVID-19 in a patient receiving clozapine: factors involved and prevention strategies to consider","volume":"22","author":"Llesuy","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psym.2020.05.025","article-title":"Clozapine toxicity in the setting of COVID-19","volume":"61","author":"Dotson","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/schbul\/sbr202","article-title":"Second-generation antipsychotic medications and risk of pneumonia in schizophrenia","volume":"39","author":"Kuo","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fnmol.2018.00349","article-title":"Challenging the negative perception of lithium and optimizing its long-term administration","volume":"11","author":"Rybakowski","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0115","first-page":"1","article-title":"Acute kidney injury in the 2019 novel coronavirus disease","volume":"323","author":"Qian","year":"2020","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0120","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40620-020-00790-5","article-title":"Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) registry","volume":"33","author":"Uribarri","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.seizure.2006.05.007","article-title":"Valproic acid induced encephalopathy \u2013 19 new cases in Germany from 1994 to 2003 \u2013 a side effect associated to VPA-therapy not only in young children","volume":"15","author":"Gerstner","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0135","first-page":"311","article-title":"Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review","volume":"8","author":"Gayam","year":"2018","journal-title":"J Commun Hosp Int Med Perspect"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0140","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver functional abnormality","volume":"18","author":"Fan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cld.967","article-title":"Interrelationship between coronavirus infection and liver disease","volume":"15","author":"Schaefer","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0150","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1139\/jpn.0312","article-title":"Interactions between the cytochrome P450 system and the second-generation antipsychotics","volume":"28","author":"Prior","year":"2003","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-a possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00002030-200107060-00010","article-title":"Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine","volume":"15","author":"DeSilva","year":"2001","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0175","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10072-020-04549-5","article-title":"Management of COVID-19 in people with epilepsy: drug considerations","volume":"41","author":"Asadi-Pooya","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11920-012-0284-9","article-title":"Clinically significant psychotropic drug-drug interactions in the primary care setting","volume":"14","author":"English","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0185","doi-asserted-by":"crossref","first-page":"200061","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0190","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.encep.2020.05.009","article-title":"Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate","volume":"46","author":"Bouaziz","year":"2020","journal-title":"Encephale"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psym.2020.05.025","article-title":"Clozapine toxicity in the setting of COVID-19","volume":"61","author":"Dotson","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239015","article-title":"Non-convulsive status epilepticus: COVID-19 or clozapine induced?","volume":"13","author":"Sokolov","year":"2020","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0220","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320959560","article-title":"Clozapine prescribing in COVID-19 positive medical inpatients: a case series","volume":"10","author":"Butler","year":"2020","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2021.02.006_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2020.05.042","article-title":"Neuroleptic malignant syndrome in a COVID-19 patient","volume":"88","author":"Kajani","year":"2020","journal-title":"Brain Behav Immun"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834321000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834321000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:52:10Z","timestamp":1759013530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834321000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"alternative-id":["S0163834321000268"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2021.02.006","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity of psychotropic drugs in patients with COVID-19: A systematic review","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}